These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 20415167

  • 21. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.
    Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M, Cioppa GD.
    Allergy; 2005 Mar; 60(3):302-8. PubMed ID: 15679714
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A multinational study of treatment failures in asthma management.
    Burney P, Potts J, Aït-Khaled N, Sepulveda RM, Zidouni N, Benali R, Jerray M, Musa OA, El-Sony A, Behbehani N, El-Sharif N, Mohammad Y, Khouri A, Paralija B, Eiser N, Fitzgerald M, Abu-Laban R.
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):13-8. PubMed ID: 18173871
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Factors associated with asthma control in primary care patients: the CHAS study].
    González Barcala FJ, de la Fuente-Cid R, Alvarez-Gil R, Tafalla M, Nuevo J, Caamaño-Isorna F.
    Arch Bronconeumol; 2010 Jul; 46(7):358-63. PubMed ID: 20227808
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment.
    Ye YM, Lee HY, Kim SH, Jee YK, Lee SK, Lee SH, Park HS.
    J Clin Pharm Ther; 2009 Dec; 34(6):693-701. PubMed ID: 20175803
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Factors related to the level of severity of asthma in primary care.
    Ställberg B, Lisspers K, Hasselgren M, Johansson G, Svärdsudd K.
    Respir Med; 2007 Oct; 101(10):2076-83. PubMed ID: 17628463
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. National Asthma Education and Prevention Program severity classification as a measure of disease burden in children with acute asthma.
    Kwok MY, Walsh-Kelly CM, Gorelick MH, Grabowski L, Kelly KJ.
    Pediatrics; 2006 Apr; 117(4 Pt 2):S71-7. PubMed ID: 16777834
    [Abstract] [Full Text] [Related]

  • 37. A multicenter survey of childhood asthma in Turkey. II: Utilization of asthma drugs, control levels and their determinants.
    Soyer OU, Beyhun NE, Demir E, Yildirim S, Boz AB, Altinel N, Cevit O, Karakaş T, Anlar Y, Söğüt A, Altintaş D, Canitez Y, Büyükdereli Z, Sekerel BE.
    Pediatr Allergy Immunol; 2009 Mar; 20(2):172-9. PubMed ID: 18823358
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Asthmatic patients' poor awareness of inadequate disease control: a pharmacy-based survey.
    Laforest L, Van Ganse E, Devouassoux G, Osman LM, Brice K, Massol J, Bauguil G, Chamba G.
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):146-52. PubMed ID: 17304881
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.